Voice-Assisted Artificial Intelligence Enabled Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics: Primary results of the VOICE-COVID-19-II Randomized Trial
Description
CONCLUSION: Alexa demonstrated comparable performance to a healthcare professional for SARS-CoV2 screening in a group of HF patients and caregivers and may represent an attractive approach to symptoms screening in this population. Future studies
